Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Ultrasound Guided Continuous Quadratus Lumborum Block Versus Continuous Paravertebral Block In Radical Cystectomy

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03547011
Recruitment Status : Completed
First Posted : June 6, 2018
Last Update Posted : January 15, 2019
Sponsor:
Information provided by (Responsible Party):
Mohammad Hazem I. Ahmad Sabry, University of Alexandria

Brief Summary:
The aim of the study to compare between intraoperative and postoperative analgesic effect of ultrasound guided continuous quadratus lumborum block and continuous thoracic paravertebral block in patients operated for radical cystectomy (primary outcome). Side effects, length of hospital stay and patient satisfaction(secondary outcome).

Condition or disease Intervention/treatment Phase
Pain, Postoperative Procedure: US guided Quadratus Lumborum block Procedure: US guided Paravertebral block. Not Applicable

Show Show detailed description

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 60 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Intervention Model Description: Double blinded randomized study.
Masking: Triple (Participant, Care Provider, Outcomes Assessor)
Masking Description: The patients, outcome assessors and care providers are not informed with the block type done.
Primary Purpose: Treatment
Official Title: The Efficacy of Ultrasound Guided Continuous Quadratus Lumborum Block Versus Continuous Paravertebral Block In Radical Cystectomy
Actual Study Start Date : September 16, 2017
Actual Primary Completion Date : June 30, 2018
Actual Study Completion Date : July 3, 2018

Arm Intervention/treatment
Active Comparator: US guided Quadratus Lumborum block
Patients will receive ultrasound guided quadratus lumborum block with 0.3 ml /kg bupivacaine 0.25% on each side with catheter insertion for maintenance doses 0.1ml/kg/hr on each side.
Procedure: US guided Quadratus Lumborum block
Patients will receive ultrasound guided quadratus lumborum block with 0.3 ml /kg bupivacaine 0.25% on each side with catheter insertion for maintenance doses 0.1ml/kg/hr on each side.

Active Comparator: US guided Paravertebral block.
Patients will receive ultrasound guided thoracic paravertebral block with 0.3 ml/kg bupivacaine 0.25 % on each side with catheter insertion for maintenance doses 0.1 ml/kg/hr on each side.
Procedure: US guided Paravertebral block.
Patients will receive ultrasound guided thoracic paravertebral block with 0.3 ml/kg bupivacaine 0.25 % on each side with catheter insertion for maintenance doses 0.1 ml/kg/hr on each side.




Primary Outcome Measures :
  1. analgesic effect [ Time Frame: 72 hours ]
    Visual Analogue Scale measure and needed postoperative analgesics.0 to 10, as 0 no pain 10 the worst pain.


Secondary Outcome Measures :
  1. Side effects [ Time Frame: 30 days ]
    numbers of side effects

  2. length of hospital stay [ Time Frame: 30 days ]
    Number of days in hospitals

  3. Patient satisfaction. [ Time Frame: 30 days ]
    Numbers from 0-10



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 99 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • • After written informed consent from each patient or oral consent if illiteracy prevent a written consent, The present study will be carried out in the Urosurgery department at Alexandria Main University hospital on 60 adult patients scheduled for radical cystectomy, males and females.

    • Patients will be randomly assigned into two equal groups (30 patients each) according to type of the block:

      1. Group I:

        Patients will receive ultrasound guided quadratus lumborum block with 0.3 ml /kg bupivacaine 0.25% on each side with catheter insertion for maintenance doses 0.1ml/kg/hr on each side.

      2. Group II:

        Patients will receive ultrasound guided thoracic paravertebral block with 0.3 ml/kg bupivacaine 0.25 % on each side with catheter insertion for maintenance doses 0.1 ml/kg/hr on each side.

        Exclusion Criteria:

    • Patient refusal.
    • Coagulopathy/ thrombocytopenia.
    • Localized infection at the proposed site of injection.
    • Inability to comprehend the scoring systems to be employed due to mental problems.
    • known allergy to the drugs to be used (local anesthetics, opioids)
    • Opioid tolerance/ dependence
    • Back abnormalities.
    • Neurological deficits.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03547011


Locations
Layout table for location information
Egypt
Alexandria Faculty of Medicine
Alexandria, Egypt, 21111
Sponsors and Collaborators
University of Alexandria
Investigators
Layout table for investigator information
Principal Investigator: Mohammad Hazem I Ahmad Sabry, MB,ChB MD Alexandria Univeristy
Publications:

Layout table for additonal information
Responsible Party: Mohammad Hazem I. Ahmad Sabry, Lecturer of Anesthesia, University of Alexandria
ClinicalTrials.gov Identifier: NCT03547011    
Other Study ID Numbers: 050108380 (13/6/2017)
First Posted: June 6, 2018    Key Record Dates
Last Update Posted: January 15, 2019
Last Verified: January 2019
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Yes
Plan Description: Data results and statistical analysis.
Supporting Materials: Study Protocol
Statistical Analysis Plan (SAP)
Informed Consent Form (ICF)
Clinical Study Report (CSR)
Time Frame: Before the start till publishing the study.
Access Criteria: not public only the researchers who can access the study information.

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Pain, Postoperative
Postoperative Complications
Pathologic Processes
Pain
Neurologic Manifestations